erythrosine has been researched along with nafamostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, O; Kitamura, N; Koshiba, M; Kumagai, S; Ryo, R; Saigo, K; Yamamoto, M | 1 |
| Ahn, M; Harsha, N; Jee, S; Jeon, BH; Jung, SB; Kang, SK; Kim, CS; Kim, DW; Kwon, SK; Lee, SD; Moon, JY; Song, HJ; Suh, KS | 1 |
2 other study(ies) available for erythrosine and nafamostat
| Article | Year |
|---|---|
Inhibition of natural killer cytotoxicity in vitro by clinical grade serine protease inhibitors.
Topics: Anti-Bacterial Agents; Antithrombin III; Benzamidines; Calcium; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Fluoresceins; Gabexate; Glycoproteins; Guanidines; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Macrolides; Serine Proteinase Inhibitors; Tumor Cells, Cultured | 2002 |
Nafamostat mesilate attenuates transient focal ischemia/reperfusion-induced brain injury via the inhibition of endoplasmic reticulum stress.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Benzamidines; Brain Edema; Brain Injuries; Disease Models, Animal; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Fluoresceins; Guanidines; Heat-Shock Proteins; Infarction, Middle Cerebral Artery; Male; Microglia; Neurologic Examination; Rats; Rats, Sprague-Dawley; Reperfusion; Transcription Factor CHOP | 2015 |